CHE:NYE-Chemed Corp (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 564.89

Change

-0.65 (-0.11)%

Market Cap

USD 7.97B

Volume

0.06M

Analyst Target

USD 565.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-1.21 (-0.35%)

USD 89.71B
THC Tenet Healthcare Corporation

-1.28 (-0.78%)

USD 15.44B
UHS Universal Health Services Inc

-2.49 (-1.21%)

USD 13.69B
DVA DaVita HealthCare Partners Inc

-0.76 (-0.48%)

USD 11.58B
EHC Encompass Health Corp

+0.08 (+0.08%)

USD 10.27B
CON Concentra Group Holdings Paren..

+0.35 (+1.73%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.14 (-0.82%)

USD 2.59B
NHC National HealthCare Corporatio..

-0.78 (-0.60%)

USD 2.08B
BKD Brookdale Senior Living Inc

-0.02 (-0.37%)

USD 1.08B
AMN AMN Healthcare Services Inc

-1.49 (-5.71%)

USD 0.99B

ETFs Containing CHE

HLTH:AU VanEck Global Healthcare .. 2.13 % 0.00 %

-0.09 (0%)

USD 0.06B
OSCV 2.02 % 0.79 %

N/A

N/A
TQSM:CA TD Q U.S. Small-Mid-Cap E.. 1.67 % 0.00 %

-0.03 (0%)

CAD 0.19B
EQWM Invesco S&P MidCap Qualit.. 0.00 % 0.25 %

N/A

N/A
OLD 0.00 % 0.50 %

N/A

N/A
JELS:LSE 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.40% 39% F 21% F
Dividend Return 0.22% 13% F 2% F
Total Return -3.17% 39% F 18% F
Trailing 12 Months  
Capital Gain -2.23% 30% F 17% F
Dividend Return 0.23% 13% F 2% F
Total Return -2.00% 30% F 15% F
Trailing 5 Years  
Capital Gain 38.64% 61% D- 65% D
Dividend Return 1.73% 14% F 5% F
Total Return 40.37% 61% D- 58% F
Average Annual (5 Year Horizon)  
Capital Gain 4.59% 30% F 51% F
Dividend Return 4.86% 30% F 45% F
Total Return 0.27% 11% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 12.26% 100% F 74% C
Risk Adjusted Return 39.62% 61% D- 57% F
Market Capitalization 7.97B 76% C+ 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.